View More View Less
  • 1 Bezmialem Vakif University, Faculty of Pharmacy, Fatih, Istanbul, Turkey
  • 2 Bezmialem Vakif University, Faculty of Pharmacy, Fatih, Istanbul, Turkey
  • 3 Bezmialem Vakif University, Faculty of Medicine, Division of Nephrologhy, Fatih, Istanbul, Turkey

Introduction: In patients with chronic kidney disease (CKD), uremic toxins accumulate in blood and cannot be excreted with urine. Accumulation of these toxins has negative effects on many body functions. Because of the importance of these toxins, we developed and validated a simple, sensitive, accurate, and precise method for the determination of two main uremic toxins: phenol and p-cresol in human urine. Materials and methods: Separation of these analytes in urine samples was achieved by reverse-phase high-performance liquid chromatography (RP-HPLC) with a C18 column at 35 °C using the mobile phase of methanol–water (65:35) at a flow rate of 1.4 mL min−1. Fluorimetric detection was used at 284 nm for excitation and 310 nm for emission. Results: The method is linear over the range of 1.5–35 ng mL−1 and 1–45 ng mL−1 for phenol and p-cresol, respectively. The method was applied to urine samples from 10 healthy subjects and 10 chronic kidney disease patients. Conclusions: This assay appears to be useful in routine analysis of clinical samples for simultaneous determination of phenol and p-cresol levels in urine.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1]

    R. Vanholder , R. De Smet, Glorieux et al., Kidney Int., 63, 1934 (2003)

  • [2]

    A. Brega , P. Prandini, C. Amaglio, and E. Pafumi, J Chromatogr., 535, 31 (1990)

  • [3]

    M. Yoshikawa , Y. Taguchi, K. Arashidani, and Y. Kodama, J Chromatogr., 362, 425 (1986)

  • [4]

    Y. Tsuruta , S. Kitai, S. Watanabe, and H. Inoue, Anal Biochem., 280, 36 (2000)

  • [5]

    R.l. Dills , G.M. Bellamy, and D.A. Kalman, J. Chromatogr. B., 703, 105 (1997)

  • [6]

    W. Kwon , J.Y. Kim, S. Suh, and M.K. In, Biomed. Chromatogr., 27, 88 (2013)

  • [7]

    C.M. Benton , L. Couchman, J.T. Marsden, D.C Rees, C. Moniz, and C.K. Lim, Biomed. Chromatogr., 26, 1033 (2012)

  • [8]

    S. Karampela , I. Vardakou, I. Papoutsis, A. Dona, C. Spiliopoulou, S. Athanaselis, and C. Pistos, J. Chromatogr. B, 902, 46 (2012)

  • [9]

    Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville MD, 2001

  • [10]

    Text on Validation of Analytical Procedures Q2A, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, London, 1994

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2020 0 10 11
Oct 2020 0 8 6
Nov 2020 0 16 15
Dec 2020 0 9 10
Jan 2021 0 14 16
Feb 2021 0 9 5
Mar 2021 0 1 2